Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Blood|August 18, 2012
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subcloneAnna L Godfrey, Edwin Chen, Francesca Pagano, et al.
Plos One|August 2, 2014
Identification of ALK gene alterations in urothelial carcinomaJoaquim Bellmunt, Shamini Selvarajah, Scott Rodig, et al.
Scientific Reports|August 24, 2022
In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastomaAinhoa Hernandez, Ana Maria Muñoz-Mármol, Anna Esteve-Codina, et al.
Frontiers in Oncology|November 6, 2023
Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancerSergi Clavé, Jennifer B Jackson, Marta Salido, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2021
Validation of a Targeted Next-Generation Sequencing Panel for Tumor Mutation Burden Analysis: Results from the Onconetwork Immuno-Oncology ConsortiumFrancesca Fenizia, Ilaria Alborelli, Jose Luis Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2016
The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal CancerFrancisco J Sánchez-Martín, Beatriz Bellosillo, Mariona Gelabert-Baldrich, et al.
Nature Communications|December 9, 2016
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancerBeth O Van Emburgh, Sabrina Arena, Giulia Siravegna, et al.
European Urology Oncology|July 14, 2026
FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result ReportingEva M Compérat, Arndt Hartmann, Yves Allory, et al.
Peerj|October 21, 2020
Validation and clinical application of a targeted next-generation sequencing gene panel for solid and hematologic malignanciesIván Prieto-Potin, Nerea Carvajal, Jenifer Plaza-Sánchez, et al.
Annals of Hematology|July 2, 2014
Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyureaAlberto Alvarez-Larrán, Luz Martínez-Avilés, Juan Carlos Hernández-Boluda, et al.
Pageof 21